155 related articles for article (PubMed ID: 28917249)
1. Challenges in imaging assessment following liver stereotactic body radiotherapy: pitfalls to avoid in clinical practice.
Yip C; Cook GJR; Owczarczyk K; Goh V
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S11. PubMed ID: 28917249
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma: imaging evaluation post treatment.
Kellock T; Liang T; Harris A; Schellenberg D; Ma R; Ho S; Yap WW
Br J Radiol; 2018 May; 91(1085):20170118. PubMed ID: 29334232
[TBL] [Abstract][Full Text] [Related]
3. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
[TBL] [Abstract][Full Text] [Related]
4. Imaging post-stereotactic body radiation therapy responses for hepatocellular carcinoma: typical imaging patterns and pitfalls.
Mastrocostas K; Jang HJ; Fischer S; Dawson LA; Munoz-Schuffenegger P; Sapisochin G; Kim TK
Abdom Radiol (NY); 2019 May; 44(5):1795-1807. PubMed ID: 30710166
[TBL] [Abstract][Full Text] [Related]
5. CT evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis: relationship between imaging appearance and baseline liver function.
Sanuki-Fujimoto N; Takeda A; Ohashi T; Kunieda E; Iwabuchi S; Takatsuka K; Koike N; Shigematsu N
Br J Radiol; 2010 Dec; 83(996):1063-71. PubMed ID: 21088090
[TBL] [Abstract][Full Text] [Related]
6. Hepatic reaction dose for parenchymal changes on Gd-EOB-DTPA-enhanced magnetic resonance images after stereotactic body radiation therapy for hepatocellular carcinoma.
Jung J; Yoon SM; Cho B; Choi YE; Kwak J; Kim SY; Lee SW; Ahn SD; Choi EK; Kim JH
J Med Imaging Radiat Oncol; 2016 Feb; 60(1):96-101. PubMed ID: 26503671
[TBL] [Abstract][Full Text] [Related]
7. [Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?].
Riou O; Valdenaire S; Debuire P; Fenoglietto P; Debrigode C; Mazard T; Assenat É; Aillères N; Azria D
Cancer Radiother; 2019 Oct; 23(6-7):636-650. PubMed ID: 31444078
[TBL] [Abstract][Full Text] [Related]
8. Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma.
Walter F; Nierer L; Rottler M; Duque AS; Weingandt H; Well J; Shpani R; Landry G; Seidensticker M; Streitparth F; Ricke J; Belka C; Corradini S
Radiat Oncol; 2021 May; 16(1):86. PubMed ID: 33957941
[TBL] [Abstract][Full Text] [Related]
9. Dose-function Histogram Evaluation Using
Toya R; Saito T; Shiraishi S; Kai Y; Murakami R; Matsuyama T; Watakabe T; Sakamoto F; Tsuda N; Shimohigashi Y; Yamashita Y; Oya N
Anticancer Res; 2018 Mar; 38(3):1511-1516. PubMed ID: 29491079
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
Choi SH; Seong J
Yonsei Med J; 2018 Oct; 59(8):912-922. PubMed ID: 30187697
[TBL] [Abstract][Full Text] [Related]
11. Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy.
Mendiratta-Lala M; Gu E; Owen D; Cuneo KC; Bazzi L; Lawrence TS; Hussain HK; Davenport MS
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1063-1069. PubMed ID: 29029891
[TBL] [Abstract][Full Text] [Related]
12. Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up.
Mendiratta-Lala M; Masch W; Shankar PR; Hartman HE; Davenport MS; Schipper MJ; Maurino C; Cuneo KC; Lawrence TS; Owen D
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):169-179. PubMed ID: 30213751
[TBL] [Abstract][Full Text] [Related]
13. Mono iso-centric VMAT planning for SBRT of multiple liver metastasis- A case report.
Barik BK; Kumari J; Sahoo DK; Majumdar SKD; Barik SK; Das DK; Parida DK
J Med Imaging Radiat Sci; 2023 Sep; 54(3):556-561. PubMed ID: 37455215
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
[TBL] [Abstract][Full Text] [Related]
15. Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma.
Oldrini G; Huertas A; Renard-Oldrini S; Taste-George H; Vogin G; Laurent V; Salleron J; Henrot P
PLoS One; 2017; 12(4):e0176118. PubMed ID: 28441447
[TBL] [Abstract][Full Text] [Related]
16. Targeting Accuracy of Image-Guided Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Real-Life Clinical Practice: In Vivo Assessment Using Hepatic Parenchymal Changes on Gd-EOB-DTPA-Enhanced Magnetic Resonance Images.
Jung J; Kim H; Yoon SM; Cho B; Kim YJ; Kwak J; Kim JH
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):867-874. PubMed ID: 29934276
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters.
Jung J; Yoon SM; Kim SY; Cho B; Park JH; Kim SS; Song SY; Lee SW; Ahn SD; Choi EK; Kim JH
Radiat Oncol; 2013 Oct; 8():249. PubMed ID: 24160910
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic Body Radiotherapy for Small Unresectable Hepatocellular Carcinomas.
Yeung R; Beaton L; Rackley T; Weber B; Hamm J; Lee R; Camborde M; Pearson M; Duzenli C; Loewen SK; Liu M; Ma R; Schellenberg D
Clin Oncol (R Coll Radiol); 2019 Jun; 31(6):365-373. PubMed ID: 30792051
[TBL] [Abstract][Full Text] [Related]
19. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
20. Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study.
Su TS; Liu QH; Zhu XF; Liang P; Liang SX; Lai L; Zhou Y; Huang Y; Cheng T; Li LQ
Radiat Oncol; 2021 Apr; 16(1):79. PubMed ID: 33882972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
